Search filters

List of works by Davide Rossi

-Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1

scientific article published on 02 November 2020

13q14 Chromosome Deletion Size and Number of Deleted Cells Influence Prognosis In Chronic Lymphocytic Leukemia ⬇️

scholarly article

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

scientific article published on 11 May 2011

14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia

scientific article published on 16 October 2008

A Laboratory Based Scoring System Predicts Early Treatment in Rai 0/Binet a CLL ⬇️

scholarly article

A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia ⬇️

scholarly article

A Multi-Center Phase I/II Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Avanced Multiple Myeloma Patients. ⬇️

scholarly article

A Phase I/II Study of Pomalidomide-Cyclophosphamide-Prednisone (PCP) in Patients with Multiple Myeloma Relapsed/Refractory to Lenalidomide ⬇️

scholarly article

A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients ⬇️

scholarly article

A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen. ⬇️

scholarly article

A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression ⬇️

scholarly article

A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients ⬇️

scholarly article

A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients ⬇️

scholarly article

A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients ⬇️

scholarly article

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia

scientific article published on 03 October 2019

A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation

scientific article published on 19 April 2022

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.

scientific article published on 20 August 2015

A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

article

ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells

article

ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter ⬇️

scientific article published on January 1, 2012

Aberrant Methylation of SHP-1 (SH2-Containing Phosphatases 1) and SOCS-1 (Suppressor of Cytokine Signalling 1) Genes in Immunodeficiency-Related Lymphomas. ⬇️

scholarly article

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

scientific article

Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.

scientific article published in February 2004

Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma

scientific article published on 24 April 2003

Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders

scientific article

Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.

scientific article published in October 2006

Absence of NOTCH1 gene mutations in MALT lymphomas

scientific article published on 16 December 2011

Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment

article

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials

scientific article

Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis/chronic lymphocytic leukemia: a new association?

scientific article

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

scientific article published on 31 August 2011

Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma

article

Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis

scientific article published on 11 October 2011

Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis.

scientific article published on 29 March 2012

Analysis of Toxicity and Efficacy of Subcutaneous Cladribine at Reduced or Standard Doses (Five Versus Seven Consecutive Days) In Patients with Hairy Cell Leukemia (HCL) In the ICGHCL2004 Protocol by the Italian Cooperative Group on Hcl ⬇️

scholarly article

Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders.

scientific article

Analysis of the Early Clonal Dynamics in Ibrutinib-Treated Chronic Lymphocytic Leukemia ⬇️

scholarly article

Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia

scientific article published on 01 July 2010

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

scientific article

Analysis of the coding genome of diffuse large B-cell lymphoma

scientific article

Anaplastic large cell lymphoma and acquired angioedema: a novel association?

scientific article

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

scientific article published on 9 April 2010

Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

scientific article published on 31 January 2011

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia

scientific article published on 10 April 2015

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

scientific article published in May 2013

Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial

scientific article

B-cell Posttransplant Lymphoproliferative Disorders in Heart and/or Lungs Recipients: Clinical and Molecular-Histogenetic Study of 17 Cases from a Single Institution

scientific article published in October 2006

B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage

scientific article published on 08 February 2011

BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma

scientific article published on 04 February 2014

BCL3 translocation in CLL with typical phenotype: assessment of frequency, association with cytogenetic subgroups, and prognostic significance

scientific article published on 01 September 2010

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

scientific article published on 27 June 2014

Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma

scientific article published in May 2010

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease

scientific article published on 22 May 2018

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

scientific article published on 31 January 2020

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome

scientific article published on 19 May 2008

Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia ⬇️

scientific article published on December 1, 2010

Biology and treatment of Richter syndrome

scientific article published on 24 April 2018

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis

scientific article published on 14 August 2020

Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab

scientific article published on 26 November 2007

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients. ⬇️

scholarly article

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

scientific article published on 05 February 2014

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

scientific article published on 12 October 2010

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival

scientific article

CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells

scientific article (publication date: February 2004)

CD38 Expression Marks CLL Cells with Invasive Properties ⬇️

scholarly article

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?

scientific article published on 18 April 2008

CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival

scientific article published on 21 April 2009

CD49d Is Overexpressed in Trisomy 12 Chronic Lymphocytic Leukemia by an Epigenetic-Dependent Transcriptional Control ⬇️

scholarly article

CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia

scientific article

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

article

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia

scientific article published on 10 February 2014

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

scientific article published on 31 January 2020

CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells ⬇️

scholarly article

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

scientific article published on 13 October 2011

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

scientific article published on 09 July 2020

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study

Central Nervous System and Intracranial Myeloma: a Retrospective Italian Multicenter Study. ⬇️

scholarly article

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

scientific article published on 23 May 2017

Circulating Mir-16 and Mir-25 As New Prognosticators For Multiple Myeloma ⬇️

scholarly article

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

scientific article published on 20 August 2018

Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias

scientific article published on 22 February 2018

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab

scientific article published on 01 November 2021

Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma.

scientific article published on 15 February 2018

Clinical Outcomes According to Genomic Abnormalities in 566 Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. ⬇️

scholarly article

Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.

scientific article published on 2 October 2012

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

scientific article

Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia

scientific article published on 27 January 2016

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

scientific article

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

scientific article

Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia

scientific article

Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia

scientific article published on 27 February 2018

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

scientific article

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

scientific article published on 9 May 2011

Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia

scientific article published on 17 March 2017

Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study

scientific article published on 09 April 2020

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

scientific article published in July 2006

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

scientific article published on 3 November 2017

Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases

scientific article published on 30 December 2020

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

scientific article published on 12 January 2011

Comprehensive Characterization of NOTCH1 Mutational Status in Chronic Lymphocytic Leukemia: Clinical Relevance of Subclonal Mutations and Mutation Types ⬇️

scholarly article

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma ⬇️

scholarly article

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

scientific article

Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models

scientific article published on 01 March 2020

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

scientific article published on 22 January 2015

Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden

scientific article published on 06 November 2019

Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.

scientific article

Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype

scientific article published on 13 June 2011

Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.

scientific article published on January 2010

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.

scientific article

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome

scientific article published on 10 May 2012

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

scientific article published on 19 May 2016

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

scientific article published on 24 January 2019

Differential Distribution Of Recurrent Gene Mutations In Subsets Of Chronic Lymphocytic Leukemia Patients With Stereotyped B-Cell Receptors: Results From A Multicenter Project Of The European Research Initiative On CLL In A Series Of 2482 Cases ⬇️

scholarly article

Diffuse large B-cell lymphoma genotyping on the liquid biopsy

scientific article

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

scientific article published on 3 February 2012

Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling

Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development.

scientific article published in July 2005

Drug-perturbation-based stratification of blood cancer

scientific article published on 11 December 2017

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

scientific article published on 04 July 2019

E2A Transcriptionally Regulates CD38 Expression In Chronic Lymphocytic Leukemia ⬇️

scholarly article

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player ⬇️

scholarly article

ETS1 Phosphorylation at Threonine-38 Is a Marker of B Cell Receptor Activation, Associating with Cell of Origin and Outcome in Diffuse Large B Cell Lymphoma ⬇️

scholarly article

Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait

article

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

scientific article published on 31 August 2010

Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor

scientific article (publication date: 2014)

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia

scientific article

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

scientific article published on 22 July 2021

Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders

scientific article published on 3 March 2008

Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival

scientific article

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.

scientific article published on 21 April 2015

Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features

article

Extra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case report.

scientific article published on 19 April 2012

Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism ⬇️

scholarly article

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

scientific article published on 3 November 2014

Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

scientific article

Free light-chains and renal disorders: when small is worse

Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients

scientific article published on 25 February 2020

Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.

scientific article published in November 2003

Functional Effects Of NOTCH1 Mutations In Chronic Lymphocytic Leukemia Patients ⬇️

scholarly article

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma ⬇️

scholarly article

Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies

scientific article published on 08 May 2013

Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness

scientific article published on 18 February 2014

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

scientific article published in June 2021

Genetic mutations in chronic lymphocytic leukemia: impact on clinical treatment

scientific article published on 06 February 2019

Genetics of follicular lymphoma transformation

scientific article

Genome Wide-DNA Profiling of HIV-Related Non-Hodgkin Lymphomas: Implications for Disease Pathogenesis and Histogenesis. ⬇️

scholarly article

Genome wide DNA-profiling of HIV-related B-cell lymphomas

scientific article published on 12 October 2009

Genome-Wide Analysis Reveals Frequent Inactivating Mutations of Acetyltransferase Genes In B-Cell Lymphoma ⬇️

scholarly article

Genome-Wide DNA Profiling Identifies a Stable Profile Although with Aberrations Targeting the Fibroblast Growth Factor Pathway in Hairy Cell Leukemia. ⬇️

scholarly article

Genome-Wide Promoter Methylation Of Hairy Cell Leukemia (HCL) ⬇️

scholarly article

Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

article

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

scientific article published on 12 July 2011

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

scientific article published on 11 December 2013

Genome-wide promoter methylation of hairy cell leukemia

scientific article published on 01 February 2019

Genomic Aberrations Dramatically Improve The Strong Prognostic Impact Of IGHV Mutational Status In Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance

scientific article published on 31 December 2020

Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia

scientific article published on 18 November 2020

Genomic profiling for clinical decision making in lymphoid neoplasms

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

scientific article published on 09 July 2019

HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism

scientific article

Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment

scientific article

Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship

scientific article published on 12 October 2011

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

scientific article published on February 2014

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.

scientific article

High-Throughput Sequencing For The Identification Of NOTCH1 mutations In Early Stage Chronic Lymphocytic Leukemia: Biological and Clinical Implications ⬇️

scholarly article

High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications

scientific article

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

scientific article published on 29 September 2020

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

scientific article published on 30 July 2020

Human herpesvirus type 8-associated primary lymphomatous effusion in an elderly HIV-negative patient: clinical and molecular characterization.

scientific article published in January 2002

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

scientific article

IGH Repertoire Analysis In Multiple Myeloma (MM): Lack of Intra-Disease Homology and Occasional Clustering with Sequences of Other B-Cell Neoplasms Sharing Identical Geographical Origin ⬇️

scholarly article

IGHD3-3fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia

scientific article published on 30 January 2012

IX. Chronic lymphocytic leukaemia: New genetic markers as prognostic factors ⬇️

scientific article published on June 1, 2013

Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort

scholarly article

Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance

scientific article published in December 2014

Identification of Anti-Lymphoma Biomarkers of Response to the Anti-CD37 Antibody Drug Conjugate (ADC) IMGN529 ⬇️

scholarly article

Identification of New Recurrent Lesions and Clinical Subsets by Genome-Wide DNA Profiling in Chronic Lymphocytic Leukemia with 17p Deletion. ⬇️

scholarly article

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Preliminary Results of the Unit Study. ⬇️

scholarly article

Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Results of the Unit Study ⬇️

scholarly article

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases

scientific article published on 30 July 2018

Impact of the host genetic background on prognosis of chronic lymphocytic leukemia

scientific article published on 01 February 2010

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

scientific article

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

scientific article (publication date: 10 March 2011)

Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.

scientific article published in March 2004

Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide

scientific article published on 22 June 2017

Inherited genetic susceptibility to monoclonal B-cell lymphocytosis

scientific article

Inherited susceptibility to chronic lymphocytic leukemia: the good candidates ⬇️

scientific article published on July 29, 2013

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

scientific article published on March 2016

Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array

scientific article published on 25 November 2011

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia

scientific article published on 15 January 2019

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

scientific article

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

scientific article published on 7 December 2016

Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.

scientific article published on 24 November 2015

International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia

scholarly article

International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia

scientific article published on 08 April 2020

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

scientific article published on 11 July 2014

JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders

scientific article published on 4 September 2006

JAK2V617F Mutation in Leukaemic Transformation of Philadelphia Negative Chronic Myeloproliferative Disorders. ⬇️

scholarly article

JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia

scientific article published on 23 July 2007

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

scientific article published on 19 September 2019

Lack of Prognostic Significance of the Conventional and Novel Prognostic Markers in Trisomy 12 Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Large Genomic Aberrations Are Independent Prognosticators of A Shorter Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia (CLL) Patients with A Normal FISH ⬇️

scholarly article

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome

scientific article published on 05 August 2019

Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant

scientific article published on 03 May 2011

Lenalidomide maintenance in high risk chronic lymphocytic leukaemia: practice changing study or hypothesis generating approach?

scientific article published on 12 September 2017

Liquid Biopsy As a Tool for Monitoring the Genotype of Diffuse Large B-Cell Lymphoma ⬇️

scholarly article

Liquid biopsy in lymphoma

scholarly article by Davide Rossi et al published 1 April 2019 in Haematologica

Long Term Response After Lenalidomide Treatment for Patients with Multiple Myeloma Relapsed After at Least Two Lines of Therapy. ⬇️

scholarly article

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL) ⬇️

scholarly article

Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome

scientific article published on 01 August 2010

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience

scientific article published on 22 July 2015

Lymphocytosis and ibrutinib treatment of CLL

scientific article published on 01 March 2014

Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing ⬇️

scholarly article

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis

scientific article

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

scientific article

MYC addiction in chronic lymphocytic leukemia ⬇️

scientific article published on February 19, 2013

MYC network mutations in high-risk chronic lymphocytic leukaemia

scientific article published on 22 January 2014

Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.

scientific article published on 27 September 2017

Marginal Zone Lymphomas

scientific article published on 01 July 2020

Mechanisms of Adaptation to Ibrutinib in High Risk Chronic Lymphocytic Leukemia ⬇️

scholarly article

Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study

scientific article published on 02 November 2018

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

scientific article

Messengers of cell death: apoptotic signaling in health and disease.

scientific article

Methods for Measuring ctDNA in Lymphomas

scientific article published on 01 January 2019

Molecular Analysis of Posttransplant Lymphoproliferative Disorders (PTLD) of Donor Origin Occuring in Liver Transplant Patients. ⬇️

scholarly article

Molecular History of Richter Syndrome: Origin From a Common Ancestor Cell Already Present at Chronic Lymphocytic Leukemia Diagnosis ⬇️

scholarly article

Molecular Lesions Of Signalling Pathway Genes In Indolent B-Cell Lymphoproliferations Mimicking Splenic Marginal Zone Lymphoma ⬇️

scholarly article

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study ⬇️

scholarly article

Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.

scientific article published on 12 June 2008

Molecular and Clinical Features of B Cell Chronic Lymphocytic Leukemia (CLL) Carrying Stereotyped B Cell Receptors: An Italian Experience. ⬇️

scholarly article

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

article

Molecular bases of chronic lymphocytic leukemia in light of new treatments

scientific article published on September 2013

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

scientific article published in August 2009

Molecular deregulation of signaling in lymphoid tumors

scientific article published on 16 April 2015

Molecular genetics of high-risk chronic lymphocytic leukemia ⬇️

scientific article published on December 1, 2012

Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis

scientific article published on August 2002

Molecular histogenesis of plasmablastic lymphoma of the oral cavity

scientific article published on 01 December 2002

Molecular histogenesis of posttransplantation lymphoproliferative disorders

scientific article published on 07 August 2003

Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis

scientific article published on 25 August 2011

Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features

scientific article published on 04 August 2014

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

scientific article published on 14 August 2015

Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature

scientific article

Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia

scientific article published on 01 October 2009

Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

scientific article

Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

scientific article published on 29 December 2011

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O· production in cancer cells

article

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

scientific article published on 27 July 2017

Mutations at 3' Untranslated Region (3'UTR) of NOTCH1 Are Associated with Low CD20 Expression Levels in Chronic Lymphocytic Leukemia ⬇️

scholarly article

Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia

scientific article published on 26 May 2017

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

scientific article

NF-κB deregulation in splenic marginal zone lymphoma

scientific article

NOTCH1 Mutated IGHV Unmutated Chronic Lymphocytic Leukemia Cells Are Characterized By a Constitutive Overexpression of Nucleophosmin-1 and Ribosome-Associated Components ⬇️

scholarly article

NOTCH1 Mutations Are Associated with Low CD20 Expression in Chronic Lymphocytic Leukemia: Evidences for a NOTCH1-Mediated Epigenetic Regulatory Mechanism ⬇️

scholarly article

NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

scientific article

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

scientific article published on 13 June 2014

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

scientific article published on 29 December 2011

NOTCH1, SF3B1 and BIRC3 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients Requiring First-LINE Treatment: Correlation with Biological Parameters and Response to Treatment ⬇️

scholarly article

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment

scientific article published in December 2014

Nicotinamide Promotes Apoptosis In Chronic Lymphocytic Leukemia through Activation of the p53/Mir-34a/SIRT1 Tumor Suppressor Network ⬇️

scholarly article

Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network

scientific article published on 12 May 2011

Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma ⬇️

scholarly article

Novel Gene Mutations In Chronic Lymphocytic Leukemia: Prevalence and Clinical Implications In A Series Of 3185 Cases - Initial Results From The European Research Initiative On CLL ⬇️

scholarly article

Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses

scientific article published on 24 April 2019

Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities ⬇️

scientific article published on May 1, 2012

Nucleophosmin-1 and Ribosome-Associated Components Are Constitutively Overexpressed in NOTCH1 Mutated IGHV Unmutated CLL ⬇️

scholarly article

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia

scientific article published on April 2009

Oprozomib in patients with newly diagnosed multiple myeloma

scientific article published on 16 August 2019

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

scientific article published on 22 November 2013

Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients ⬇️

scholarly article

Overview of non-coding mutations in chronic lymphocytic leukemia

scholarly article by Valeria Spina & Davide Rossi published 1 January 2019 in Molecular Oncology

POEMS and calciphylaxis: a novel association?

scientific article published on 01 October 2004

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

scientific article

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

scientific article

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

scientific article

Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia

scientific article published on 3 November 2016

Predictive markers and driving factors behind Richter syndrome development

scientific article published on March 2011

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

scientific article published on 24 July 2018

Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance

scientific article

Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entity

article

Prognostic Models to Predict Survival In Indolent and Aggressive Non-Hodgkin's Lymphomas Associated with Hepatitis C Virus Infection: a Multicenter Italian Study on 1,043 Patients. ⬇️

scholarly article

Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia

scientific article published on 21 December 2007

Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells

scientific article

Prognostic relevance of MYD88 mutations in CLL: the jury is still out.

scientific article published on August 2015

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.

scientific article published on 2 April 2017

Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma

scientific article published on 21 August 2013

Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance

scientific article

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial

scientific article published on 01 August 2020

Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related Satellites ⬇️

scholarly article

Recent advances in understanding the biology of marginal zone lymphoma.

scientific article

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

scientific article

Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations

scientific article published on 16 February 2020

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age ⬇️

scholarly article

Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience

scientific article published on 31 May 2010

Reply to Aron P. Kater et al

scientific article published on 01 July 2020

Reply to J. Wang et al

scientific article published on 12 February 2019

Richter syndrome

scientific article published on January 2013

Richter syndrome and fludarabine: a controversial relationship ⬇️

scientific article published on September 10, 2012

Richter syndrome: molecular insights and clinical perspectives

scientific article

Richter syndrome: pathogenesis and management

scientific article published on 15 February 2016

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

scientific article published on 21 February 2018

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

scientific article published on 15 July 2020

Role of PET/CT in the Diagnostic Work-up of Patients with Chronic Lymphocytic Leukemia (CLL) and Clinical Signs of Disease Progression ⬇️

scholarly article

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

scientific article published on 30 November 2015

SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy ⬇️

scholarly article

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS) ⬇️

scholarly article

SNP6 Array Better Defines Chronic Lymphocytic Leukemia (CLL) Prognostic Groups ⬇️

scholarly article

SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia

scientific article published on 17 September 2020

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment

scientific article published on 27 September 2011

Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.

scientific article

Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia

article

Simian virus 40 infection in lymphoproliferative disorders

scientific article published in January 2003

Simian virus 40 infection in lymphoproliferative disorders

scientific article published in The Lancet

Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia

scientific article published on 29 November 2006

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

article by Andrea Rinaldi et al published 3 March 2010 in British Journal of Haematology

Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia ⬇️

scholarly article

Splenic marginal zone lymphoma: from genetics to management

scientific article published on 17 March 2016

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

scientific article published on 09 June 2009

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

scientific article (publication date: October 2010)

Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis

scientific article published in January 2014

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

scientific article published on 14 April 2020

TP53 Mutations, the Most Frequent Genetic Lesion in Richter Syndrome, Represent An Independent Predictor of Survival Post Transformation. ⬇️

scholarly article

Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors ⬇️

scholarly article

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

scientific article published on 27 September 2018

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models

scientific article published on 09 January 2020

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

scientific article

Targeting the Epigenome and the Cell Signaling As Novel Therapeutic Approaches for Splenic Marginal Zone Lymphoma ⬇️

scholarly article

The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents

scientific article published on 24 January 2019

The Coding Genome of Nodal Marginal Zone Lymphoma Reveals Recurrent Molecular Alterations of PTPRD and Other Jak/Stat Signaling Genes ⬇️

scholarly article

The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study ⬇️

scholarly article

The Host Genetic Background of DNA Repair Mechanisms Represents An Independent Predictor of Progression and Survival in Diffuse Large B-Cell Lymphoma Treated with R-CHOP. ⬇️

scholarly article

The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.

scientific article published on 10 January 2012

The Molecular Profile of Richter Syndrome Predicts Survival From Transformation: The Role of Clonal Relationship ⬇️

scholarly article

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

scientific article published on 03 March 2009

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection

scientific article published on 7 November 2014

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.

scientific article published on 8 January 2013

The Pan Class-I PI3K Inhibitor Copanlisib Has Preclinical Activity in Mantle Cell Lymphoma, Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia As Single Agent and in Combination with Other Targeted and Conventional Agents ⬇️

scholarly article

The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.

scientific article

The clinical implications of gene mutations in chronic lymphocytic leukaemia

scientific article

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

scientific article

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

article

The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA

scientific article published on 30 December 2019

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

scientific article published on 25 January 2011

The genetics of nodal marginal zone lymphoma

scientific article published on 22 June 2016

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

scientific article

The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

scientific article

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

scientific article published in December 2017

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models

scientific article published on 07 February 2019

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

scientific article published on 5 May 2009

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness

scientific article published in February 2009

The spectrum of genetic defects in chronic lymphocytic leukemia

scientific article

Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma

scientific article published on 22 August 2018

Tracking the biological risk of coronary artery disease in HIV-infected individuals: the case of circulating endothelial progenitor cells

scientific article published in January 2011

Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection.

scientific article published on December 2007

Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia

scientific article

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

scientific article published on 4 September 2013

Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0) ⬇️

scholarly article

Usage of IGHV4-39 with Stereotypic B Cell Receptor Is An Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome ⬇️

scholarly article

Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera

scientific article (publication date: 2007)

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

scientific article published on 20 March 2018

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

scientific article published on 22 August 2016

Venetoclax plus daratumumab induce hematological CR and organ response in an AL amyloidosis patient with t(11;14)

scientific article published on 22 June 2019

Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCd) in Newly Diagnosed Multiple Myeloma Patients: A Phase I- II Study ⬇️

scholarly article

Whole Transcriptome Sequencing In Refractory T-Cell Acute Lymphoblastic Leukemia ⬇️

scholarly article

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

scientific article published on 16 December 2015

miRNAs involvement in the pathogenesis of Richter's syndrome

scholarly article by Katrien Van Roosbroeck et al published 8 November 2018 in Haematologica

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

scientific article published on 14 May 2013

Paulina is supported by:

About Paulina

Help